Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Choitec Pharmaceutical Co., Ltd. is a science and technology-driven pharmaceutical company based in Haikou, China, specializing in the research, development, manufacturing, and sales of anti-tumor preparations and active pharmaceutical ingredients (APIs). Established in 2016, the company operates GMP-certified production lines for various dosage forms, including lyophilized powder injections, tablets, and drops, with a strong focus on oncology. Choitec utilizes advanced technology platforms such as enzyme reaction and microchannel reaction to ensure green and efficient production of emergency and high-end drugs. In addition to its own product portfolio, the company provides comprehensive CMO and MAH services, positioning itself as a one-stop solution provider for drug development and commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ChoiTec Pharma.